1-tert-Butyl 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate

Catalog No. :
ACMRGU416
CAS No. :
1303973-86-5
Molecular Formula :
C12H19F2NO4
Molecular Weight :
279.28

IUPAC Name:1-(tert-butyl) 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate

1-tert-Butyl 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$153.00Login to see priceInquiryInquiry
250mg98%$255.00Login to see priceInquiryInquiry
1g98%$636.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-tert-Butyl 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate
IUPAC Name1-(tert-butyl) 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate
Molecular FormulaC12H19F2NO4
Molecular Weight279.28
SMILESO=C(N1CC(F)(F)C(C(OC)=O)CC1)OC(C)(C)C
InChI KeyQYHGUUKIPMWLMC-UHFFFAOYSA-N
Synonym1,4-Piperidinedicarboxylic acid, 3,3-difluoro-, 1-(1,1-dimethylethyl) 4-methyl ester;1-(tert-Butyl) 4-methyl 3,3-difluoropiperidine-1,4-dicarboxylate
CAS No.1303973-86-5
PubChem CID105530168

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMRGU416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSCGI649 route compound structure diagram
    ACSCGI6491779974-06-9 In Stock
  4. Then
  5. ACMRGU416 route product structure diagram
    ACMRGU4161303973-86-5
Inquiry

2. ACMRGU416 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRGU416 route product structure diagram
    ACMRGU4161303973-86-5
Inquiry

Comments (0)